Fylde and Wyre CCG Medicines Optimisation

Click each header to expand its content

Fylde and Wyre medicines RAG list

Application forms

Medicines commissioning policies

NameSizeHits
Actipatch for pain management 0.6 MB184
Albiglutide for type-2 diabetes mellitus 0.3 MB119
Alprostadil Cream For ED 0.3 MB96
Azelastine Fluticasone (Dymista) Nasal Spray 0.1 MB155
Bazedoxifene for oestrogen deficiency symptoms 0.3 MB108
Botulinum Toxin A for Spasticity and Contracture of the joint 0.3 MB116
Brimonidine For Erythema Of Rosacea 0.1 MB104
Brivaracetam for epilepsy 0.3 MB105
Budesonide multimatrix MMX 9mg prolonged release tablets 0.2 MB136
Certolizumab For Psoriatic Arthritis 0.1 MB86
Co-Proxamol For pain management 0.3 MB222
Co-trimoxazole for the prophylaxis of pneumocystis jirovecii (pneumocystis carinii) infections 0.3 MB110
Co-trimoxazole Prophylaxis of Primary and Secondary Spontaneous Bacterial Peritonitis (SBP) 0.1 MB112
Colesevelam (Cholestagel® ) For combination or monotherapy for familial hypercholesterolaemia 0.3 MB105
Colistimethate sodium/Colistin sulfomethate sodium (Colomycin® ) For non-Cystic Fibrosis in Patients with Bronchiectasis Colonised with Pseudomonas Aeruginosa 0.2 MB75
Conditions for which over the counter items should not routinely be prescribed in primary care 0.9 MB219
Daily selective serotonin re-uptake inhibitors (SSRIs) for the treatment of premature ejaculation (PE) 0.2 MB76
Dapoxetine for the treatment of premature ejaculation (PE) 0.2 MB80
Denosumab for GIO 0.2 MB58
Dulaglutide for the treatment of Type II Diabetes Mellitus in adults 0.3 MB116
Eflornithine-cream-for-facial-hirsutism 0.2 MB105
Eltrombopag For Thrombocytopenia In Hepatitis C 0.1 MB68
Eslicarbazepine For Focal Seizures 0.1 MB91
Evolocumab (Repatha SureClick® ) For prevention of cardiac events in patients with CHD and a history of ACS, in combination with a statin 0.1 MB106
Ferric Maltol 30mg Capsules in Adults for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease 0.3 MB109
Fluorouracil-5-cream-for-basal-cell-carcinomas 0.1 MB65
Gluten-Free-Food-Products 0.3 MB106
Guanfacine-for-ADHD 0.3 MB91
Imiquimod-5-cream-for-basal-cell-carcinomas 0.2 MB90
Insulin Degludec And Liraglutide 0.2 MB87
Insulin-Aspart-for-Diabetes-Mellitus 0.3 MB99
Insulin-Degludec-for-DM 0.3 MB101
Insulin-Detemir-for-DM 0.2 MB75
Insuline-Glargine-for-T1DM 0.3 MB80
Insuline-Glargine-for-T2DM 0.3 MB85
Invicorp-injection-for-erectile-dysfunction 0.3 MB115
Ivermectin-cream-for-rosacea 0.3 MB98
JIA Policy For Adults (Version 1.0) 0.2 MB74
Lamotrigine-for-trigeminal-neuralgia 0.3 MB91
Lamotrigine-for-trigeminal-neuralgia 2 0.3 MB113
Levonorgestrel 13.5mg IUD 0.3 MB73
Lidocaine Plasters For PHN 0.2 MB84
Lidocaine-plasters-for-unlicensed-indications 0.3 MB157
Liothyronine-for-refractory-hypothyroidism 0.2 MB122
Liraglutide-for-obesity 0.3 MB99
Lisdexamfetamine-for-ADHD-in-adults 0.3 MB104
Lisdexamfetamine-for-ADHD-update 0.3 MB89
Lurasidone-for-Schizophrenia 0.3 MB110
Magnaspartate For Hypomagnesaemia 0.3 MB159
Metformin-for-reductionof-risk-or-delay-type-2-daibetes 0.2 MB81
Metformin-for-reductionof-risk-or-delay-type-2-daibetes 2 0.2 MB65
Midazolam-Epistatus-for-seizures 0.2 MB109
Opicapone-for-Parkinsons-disease-v2 0.5 MB117
Ospemifene for VVA 0.2 MB107
Oxycodone-Naloxone-for-Restless-legs 0.3 MB79
Paravit-CF-for-dietary-management-of-patients-with-cystic-fibrosis 0.2 MB281
Patiromer-for-hyperkalaemia 0.3 MB81
Patiromer-for-hyperkalaemia 2 0.3 MB102
Phosphodiesterase Type-5 Inhibitors 0.2 MB72
Pitolisant-for-Narcolepsyv2 0.3 MB86
Policy On Brand Inhaler Prescribing 0.3 MB105
Probiotics And VSL 0.3 MB91
Relvar Ellipta for COPD and asthma in adults 63 KB75
Rituximab-for-AIHA 0.4 MB103
Rituximab-for-ITP 0.4 MB87
Rivaroxaban-10mg-for-DVT-and-PE-and-extended-use 0.1 MB95
Safinamide-for-Parkinsons-disease 0.3 MB109
Second Line Anti-TNF For PsA 0.2 MB93
Second-generation-LA-antipsychotics 0.3 MB106
Secukinumab-for-Palmoplantar-psoriasis 0.3 MB78
Secukinumab-for-Palmoplantar-psoriasis 2 0.3 MB84
Semaglutide for type 2 DM 0.2 MB54
Silk Garments For Eczema And Dermatitis 0.2 MB74
Simbrinza for chronic open angle glaucoma 0.1 MB70
Sodium Oxybate for Narcolepsy with Cataplexy 0.3 MB99
Spironolactone For Acne 0.1 MB104
Subcutaneous Depot Medroxyprogesterone Acetate 0.1 MB88
Tadalafil daily 0.3 MB119
Tapentadol for neuropathic pain in non-palliative care 0.4 MB104
Tapentadol for non-specific pain 0.2 MB91
Testosterone For Female Sexual Dysfunction 0.1 MB65
Tiotropium For Asthma 0.2 MB69
Tocilizumab SC For RA 0.1 MB69
Trelegy inhaler for COPD 0.3 MB108
Trimbow inhaler for COPD 0.4 MB111
Trimbow-inhaler-for-COPD 0.4 MB6
Ulipristal acetate for uterine fibroids 0.5 MB93
Umeclidinium For COPD 0.2 MB65
Vedolizumab For Crohn's Disease 0.2 MB60
Vesomni For Benign Prostatic Hyperplasia 0.1 MB75
Vitamins (inc Renavit) For Dialysis 0.3 MB107
Waterproof Cast Cover Policy 0.1 MB158
Xonvea for nausea and vomiting in pregnancy 0.1 MB58

Medicines guidelines, information sheets, and shared care

Further medicines guidelines are available on Lancashire Medicines Management Group’s website.

NameSizeHits
Algorithm-for-antihyperglycaemic-therapy-in-adults-with-type-II-v1.5[3] 0.5 MB5
Azathioprine-Mercaptopurine-SCG-Version 0.2 MB180
BGTS and Meters Guideline Nov16 1.2 MB546
Cannabis-based-medicinal-products-for-pain-POSITION-STATEMENT-version-1.1[1] 0.3 MB3
Ciclosporin-SCG-Version 0.2 MB103
Commissioining Policy For Nutritional Supp Post Bariatirc Surgery Apr13 83 KB96
Conditions-for-which-OTC-items-should-not-routinely-be-prescribed-in-pri .. 0.9 MB134
Dalteparin SCG 2018 0.2 MB89
Electronic-Repeat-Dispensing-guideline 1.7 MB544
Emollient-Guideline-May-2017 0.2 MB430
Flash Glucose Monitoring policy - L&SC 0.2 MB59
Flowchart-for-Vitamin-D-Deficiency-in-Primary-Care 0.3 MB258
Guidance to support the implementation of the valproate PREVENT programme 0.5 MB123
Guidance-for-7-day-prescriptions-FWCCG-Apr2018 0.5 MB169
Leflunomide-SCG-Version 0.2 MB90
LSCMMG OTC Items that Should not be Routinely Prescribed in Primary Care... 0.2 MB7
MDS Briefing Doc Oct 13 43 KB68
Methotrexate-SCG-Version 0.2 MB170
Mgt-of-Infection-Primary-Care-Guidance-January-2017-version2 0.7 MB478
Patient information - Emollients.steroid.barrier creams 0.2 MB57
Patient information - Emollients.steroid.barrier creams 0.2 MB127
Patient information - spacer devices 0.2 MB87
Patient information - spacer devices 0.2 MB54
Penicillamine-SCG-Version 0.2 MB78
Policy Unlicensed Herbal Vits Mins Supplements 2013 77 KB55
Position Statement OPIOID PRESCRIBING max dose Final Version 1.1 0.1 MB8
Prescribing-Nutritional-Supplements-Post-Bariatric-Surgery-Version-1.2[1] 0.3 MB3
Prescribing-Nutritional-Supplements-Post-Bariatric-Surgery-Version-1.2[1] 0.3 MB3
RMOC-Liothyronine-Guidance-v2.0-final-1 0.5 MB58
Sodium-Aurothiomalate-SCG-Version 0.2 MB17
Sulfasalazine 0.2 MB130
Testosterone-Shared-Care-Guideline-Version-1.2[1] 0.3 MB3
Wound Care Formulary 8.2 MB482

Primary care rebate schemes

Primary care rebate schemes are contractual arrangements offered by pharmaceutical companies, or third party companies, which offer retrospective financial rebates to the CCG on GP prescribing expenditure for particular branded medicine(s). The availability of a scheme does not influence the inclusion of specific medicines in care pathways or formularies.

Current Primary Care Rebate Schemes in place:

  • Clenil Modulite (Beclometasone) – Started July 2019
  • Fencino (Fentanyl) – Started April 2016
  • Firmagon (Degarelix) – Started September 2016
  • Januvia (Sitagliptin) – Started September 2018
  • Lixiana (Edoxaban) – Started February 2018
  • Longtec (Oxycodone SR) – Started July 2019
  • Sereflo (Fluticasone / Salmeterol) – Started July 2019
  • Seretide (Fluticasone / Salmeterol) – Started April 2016
  • Xarelto (Rivaroxaban) – Started October 2019
  • Zoladex (Goserelin) – Started January 2019

Fact and advice sheets

Inhaler Techniques

Inhaler technique videos are available to view online.

Last updated on 18 December 2019 at 11:14 by communications and engagement manager